A

new political action group taking on high drug prices has big plans in the works leading up to November’s midterm elections — and a seven-figure budget to make it happen.

David Mitchell, a cancer patient and the former head of a Washington, D.C., public policy firm, last week unveiled the new organization, called Patients for Affordable Drugs NOW. It’s a separate legal entity operating as the political arm of the advocacy group Patients for Affordable Drugs that Mitchell founded last year. Initial funding comes from an entity financed by the billionaire couple John and Laura Arnold, who’ve spent millions backing other research and advocacy on drug pricing.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I am a cancer patient my drug last year started at $8000. Yes $8000. Now it is $11000.
    I know someone who worked for Bch/bs and the trips bonuses are what is driving our costs up. I’m with you

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.